1. Inicio
  2. Proyectos y Estudios
  3. A randomized, double-blind, placebo-controlled, parallel group, Phase 3 study, followed by open-label extensions, to evaluate the efficacy of oral belumosudil in adult participants with chronic lung allograft dysfunction (CLAD) following bilateral lung transplantation.

A randomized, double-blind, placebo-controlled, parallel group, Phase 3 study, followed by open-label extensions, to evaluate the efficacy of oral belumosudil in adult participants with chronic lung allograft dysfunction (CLAD) following bilateral lung transplantation.

Datos básicos

Código:
EFC17801
Protocolo:
EFC17801
EUDRACT:
2023-503462-23
NCT:
Centro:
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Dotación:
Año de incio:
2023
Año de finalización:
ENSAYO CLÍNICO

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

SANOFI AVENTIS S.A

Resultados del Ensayo Clínico

Cystic Fibrosis: From Salty Malediction to Possible Cure.

Sole, Amparo, Davies, Jane C., Quintana-Gallego, Esther

Editorial Material. 10.1016/j.arbres.2023.10.007. 2023


Discordance between humoral and cellular immune responses to cytomegalovirus infection in CMV seropositive patients awaiting lung transplantation

Boada-Perez, Meritxell; (...); Gomez-Olles, Susana

Article. 10.3389/fimmu.2024.1445553. 2025

  • Open Access.

Genomic characterization of MRSA recovered from people with cystic fibrosis during two Spanish multicentre studies (2013 and 2021).

Maruri-Aransolo A; (...); Caballero-Pérez JD

Article. 10.1093/jacamr/dlae160. 2024

  • Open Access.

Pregnancy and fertility in people with cystic fibrosis following lung transplantation.

Taylor-Cousar JL, Sole A, Jain R

Article. 10.1097/MCP.0000000000001117. 2024

  • Open Access.

Campos de estudio

Compartir